Statement of Commissioner Christine S. Wilson in the Matter of Pfizer Inc./Mylan N.V.

Tags:

• Health Care
• Prescription Drugs
• Manufacturing
• Pharmaceuticals
• Competition
• Merger
• Horizontal
• generic drugs
• market power
• Bureau of Competition
• Commissioners